[velcro]

Johnny, we've got to wonder how such a rotten financial manager as GC can keep landing on his feet.
Hard luck research companies need people like GC with a good line of quality horse manure.
Learning what doesn't work creates more opportunity for the next experiment.

[Monksdream]

OSTX under $2

[swingingRichard]

OSTX being promoted by some pr firm called RedChip on Bloomberg. 

[tw0122]

$1.92 ..The Company recently completed a $7.1 millionfinancing in January 2025 and has sufficient capital into mid 2026..
(2) sell the Priority Review Voucher (PRV) it would receive from the FDA BLA approval prior to the September 30, 2026 PRV deadline to a larger pharmaceutical company at prevailing market prices (most recent PRV sale transaction was $150 million), (3) commercialize OST-HER2 in osteosarcoma and (4) then expand the clinical development of OST-HER2 into breast cancer and other larger solid tumor indications for additional revenue potential.

[Rotten Johnny]

too much debt AND the CBO is a lying POS shyster who destroys SH value



C-Suites my royal right butt cheek ...!

just look at what Gerald Commissiong did to AMBS and TOMDF

drove both into insolvency and stole everything he could via serial dilution from his SH's

its just that plain and simple...!



Gerald Commissiong - WAPOS

[tw0122]

Yes only played premarket to much debt here 

[Monksdream]

OSTX under $3

[Rotten Johnny]

don't touch it...

unless you're Jack be nimble Jack be quick...

AJMHO

[tedpeele]

I'm seeing 1.6m float

[glenn1919]

OSTX...................................................newone.....................................https://stockcharts.com/h-sc/ui?s=ostxp=W&yr=1&mn=3&dy=0&id=p96837884856

[tw0122]

$4.10 + 104% went to $5s last run January but profit taking hitting bigger now 

[Rotten Johnny]

I wouldn't touch ANYTHING Gerald Commissiong is involved with...

did you see the last P&D they pulled in Dec., 24

AJMHO

[tw0122]

$3.36 + 70% Guess will find out later flip out time ..
 The Company anticipates submitting a Biologics Licensing Application (BLA) to the US FDA for OST-HER2 in osteosarcoma in 2025 and, if approved, would become eligible to receive a Priority Review Voucher that it could then sell. OST-HER2 has completed a Phase 1 clinical study primarily in breast cancer patients, in addition to showing preclinical efficacy data in various models of breast cancer. OST-HER2 has been conditionally approved by the U.S. Department of Agriculture for the treatment of canines with osteosarcoma.

[Rotten Johnny]

interesting - wonder where they'll get their funding

and if it will be toxic - Gerald...?

[tw0122]

OSTK 3.06 + 52% 

[tw0122]

OSTX $2.30 + 15% .. NEW YORK--(BUSINESS WIRE)--Feb. 14, 2025--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has entered into agreements for the commercial manufacture of OST-HER2. 

[tw0122]

Didn't trade it but see you under $4 maybe lol thanks

[TheFinalCD]

$OSTX in yesterday's filing pic.twitter.com/2l25LO7e3J

— brentkhack (@brentkhack_TX) January 15, 2025

[tw0122]

Lung action $8s + 92% 17m floater 

[Rotten Johnny]

looking good Gerald...!

IMHO, you'll have this trading at $0.00028 in record time



here comes the Astoria Queens financial mafia wrecking crew to help assist you in your next financial debacle

so much for running TOMDF into insolvency and jumping ship to this firm which didn't last long:

Fortitude Advisors LLC

https://fortitudeadvisors.com/team/

"He is also the Chief Business Officer at OS Therapies, Inc. starting in 2024 and the Managing Partner at Fortitude Advisors LLC since 2019."

https://uk.marketscreener.com/insider/GERALD-COMMISSIONG-A19LFK/

I give Gerald Commissiong 6 months before OSTX fire's his arse - and for good measure...!

MOO pathetic

[Rotten Johnny]

uh ho - Gerald Commissiong OSTX's new Chief Business Officer executive named...

and is the same old same old serial dilution 'scam artist' from AMBS & TOMDF

here we go again folks...!



buyers be ware - check these other 2 tickers for the catastrophic results by this Stanford Univ. Financial Engineering hack

https://ostherapies.com/leadership/

SMH - can't make this stuff up - sad but true...!

MOO tool